The Food and Drug Administration approved new mRNA coronavirus vaccines Thursday, clearing the way for shots manufactured by Pfizer-BioNTech and Moderna to start hitting pharmacy shelves and doctor’s ...

While promising coronavirus vaccine candidates could aid in bringing the pandemic to its heels, doctors recommended to federal health officials this week that those who eventually receive the ...

As updated coronavirus vaccines hit U.S. pharmacy shelves, adults without health insurance are discovering the shots are no longer free, instead costing up to $200. The federal Bridge Access Program ...

There’s no indication that the coronavirus’ tenure is ending. FLiRT is the newest variant that now accounts for the large majority of COVID-19 cases, according to Yale Medicine. Its strains include KP ...

The ongoing Phase 3 clinical trial of Pfizer/BioNTech's coronavirus vaccine confirms its protection lasts at least six months after the second dose, the companies said Thursday. The companies can now ...

A study found that covid-19 vaccines appeared to awaken the immune system in lung and skin cancer patients, helping them live ...

"It's of course very aggressive -- but it is possible," a scientist says. With top White House officials indicating a coronavirus vaccine may be available by January 2021, scientists and vaccine ...

Covid-19 vaccines may do far more than prevent severe coronavirus infections — a new study suggests they could supercharge ...